Dual Inhibitors of PARPs and ROCKs.
Loading...
Embargo End Date
ICR Authors
Authors
Antolín, AA
Mestres, J
Mestres, J
Document Type
Journal Article
Date
2018-10-31
Date Accepted
2018-09-24
Abstract
Recent network and system biology analyses suggest that most complex diseases are regulated by robust and highly interconnected pathways that could be better modulated by small molecules binding to multiple biological targets. These pieces of evidence recently led to devote efforts on identifying single chemical entities that bind to two different disease-relevant targets. Here, we first predicted in silico and later confirmed in vitro that UPF 1069, a known bioactive poly(ADP-ribose) polymerase-1/2 (PARP1/2) molecule, and hydroxyfasudil, a known bioactive Rho-associated protein kinase-1/2 (ROCK1/2) molecule, have low-micromolar cross-affinity for ROCK1/2 and PARP1/2, respectively. These molecules can now be regarded as chemical seeds from which pharmacological tools could be generated to study the impact of dual inhibition of PARPs and ROCKs in preclinical models of a variety of complex diseases where both targets are involved.
Citation
ACS omega, 2018, 3 (10), pp. 12707 - 12712
Source Title
Publisher
AMER CHEMICAL SOC
ISSN
2470-1343
eISSN
2470-1343